Market Place
Sourcing Support
MedAlliance acquired by Cordis for $1.13 billion
17 Nov 2023 //
ECONOMIC TIMES
MedAlliance Announces Enrollment of 1,660 Patients in SELUTION DeNovo Study
14 Sep 2023 //
PR NEWSWIRE
MedAlliance announces enrollment of First Patient in SELUTION SLR LOVE-DEB
05 Sep 2023 //
PR NEWSWIRE
MedAlliance announces completion of enrollment in SAVE Trial with SELUTION SLR
16 Aug 2023 //
PR NEWSWIRE
MedAlliance announces completion of enrollment in SAVE Trial with SELUTION SLR
15 Aug 2023 //
PR NEWSWIRE
MedAlliance SELUTION SLR is the 1st DEB to receive coronary de novo IDE approval
10 Jan 2023 //
PR NEWSWIRE
MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval
25 Oct 2022 //
PRNEWSWIRE
Cordis absorbs drug-eluting balloon maker MedAlliance for $235M
20 Oct 2022 //
FIERCEBIOTECH
MedAlliance to be Acquired by Cordis
18 Oct 2022 //
PRNEWSWIRE
MedAlliance SELUTION SLR Receives Second FDA IDE Approval
09 Aug 2022 //
PRNEWSWIRE
MedAlliance secures FDA IDE approval for SELUTION SLR drug eluting balloon
31 May 2022 //
NSMEDICALDEVICES
MedAlliance`s SELUTION SLR drug-eluting balloon (DEB) receives FDA IDE approval
26 May 2022 //
PRNEWSWIRE
MedAlliance announces completion of enrollment in Japanese SELUTION SLR™ Study
22 Sep 2021 //
PRNEWSWIRE
MedAlliance completes patient enrollment in PRISTINE trial
14 Aug 2021 //
PHARMABIZ
MedAlliance announces successful completion of enrolment in ISABELLA trial
24 Nov 2020 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.